Anti-PD-L1 for metastatic triple-negative breast cancer.
Josefine
J
Gibson
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D060890:B7-H1 Antigen / Q000276:immunology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D064726:Triple Negative Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D060890:B7-H1 Antigen; C423236:CD274 protein, human; C000594389:atezolizumab